Does Aetna Cover Ozempic for Weight Loss? Wegovy, Zepbound, and Denials

Aetna does not cover Ozempic for weight loss. The drug is approved by the FDA only for type 2 diabetes and related cardiovascular and kidney risks, and Aetna’s pharmacy policy follows that label strictly. If your doctor prescribes Ozempic off-label to help you lose weight, the claim will be denied. You may still have options: Aetna may cover Wegovy or Zepbound for weight management under separate policies, but only if your employer’s plan includes that benefit.

Why Aetna Will Not Pay for Ozempic as a Weight-Loss Drug

The reason comes down to the FDA label. Ozempic (semaglutide) is approved to improve blood sugar control in adults with type 2 diabetes, to reduce cardiovascular risk in adults with type 2 diabetes and established heart disease, and to slow kidney disease progression in adults with type 2 diabetes and chronic kidney disease.¹ Weight loss is not on that list. Prescribing it for weight management in a patient without diabetes is off-label use.²

Aetna’s pharmacy policy for Ozempic (Policy 2439-C) limits coverage to patients with a confirmed diagnosis of type 2 diabetes mellitus and does not list weight loss as an approved indication.³ Aetna’s broader medical policy on weight-reduction programs also leaves Ozempic off the list of covered weight-management medications.⁴

Wegovy contains the same active ingredient as Ozempic but is FDA-approved specifically for chronic weight management.⁵ That regulatory distinction is why insurers treat the two products so differently, even though they share a molecule at different doses.

When Aetna Does Cover Ozempic

If you have type 2 diabetes, Ozempic is a covered drug. It appears on the 2026 Aetna Standard Plan formulary as a preferred antidiabetic agent, and once approved, the authorization runs for 36 months.⁶³

For patients not already on a GLP-1 medication, approval requires meeting at least one of these criteria:

Inadequate response to, intolerance of, or contraindication to metformin.
A need for combination therapy with an A1C of 7.5% or greater.
An estimated glomerular filtration rate below 30 mL/min/1.73m².
A documented history of heart attack, stroke, or related cardiovascular disease.

Patients already on a stable dose for at least three months must show a reduction in A1C since starting therapy, or have advanced kidney disease or established cardiovascular disease, to continue.³ If you have one of these qualifying diagnoses, that is the realistic path to coverage. Arguing for Ozempic purely as a weight-loss drug will not work with Aetna.

Wegovy and Zepbound: The Weight-Loss GLP-1 Drugs Aetna May Cover

Aetna has clinical policies that cover Wegovy and Zepbound for weight management, but whether your plan actually includes that benefit depends on your employer. Many Aetna benefit plans explicitly exclude services and medications for obesity, diet, or weight control.⁴ Employers choose whether to include GLP-1 drugs for weight management when they build the plan.⁷ Some employers select a “100% member copay” option, which lets you fill the prescription through the plan’s pharmacy network but requires you to pay the full cost yourself.⁸

Check your Summary of Benefits and Coverage, or call the number on your member ID card, to find out whether your plan covers weight-loss medications before you go through a prior authorization that may be rejected on plan-exclusion grounds alone.

Wegovy

Under Aetna’s commercial policy (4774-C), adults must have participated in a comprehensive weight management program — behavioral modification, reduced-calorie diet, and increased physical activity — for at least six months before starting Wegovy. The BMI threshold is 30 kg/m² or higher, or 27 kg/m² with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol. Initial approval lasts seven months. To continue, patients must show at least 5% weight loss from baseline or maintain a previous 5% loss.⁹

Wegovy is also covered separately for cardiovascular risk reduction in adults with established heart disease and a BMI of 27 or higher who do not have type 2 diabetes. The policy specifies that patients with type 2 diabetes should use Ozempic for that purpose instead.¹⁰

Zepbound

Zepbound (tirzepatide) follows a similar framework: six months in a comprehensive weight management program, a BMI of 30 or higher (or 27 with a comorbidity), and a requirement to show 5% weight loss within three months of reaching a maintenance dose in order to continue coverage.¹¹

Aetna Medicaid Plans Are Stricter

Some Aetna Medicaid plans exclude Wegovy and Zepbound for weight loss entirely. Under Aetna’s Medicare HIDE Medicaid plan, GLP-1 agents for weight loss are non-preferred: patients must have tried and failed five different preferred non-GLP-1 weight-loss drugs, carry a BMI of 40 or higher, and have a prescriber attestation that the medication is being used to avoid bariatric surgery.¹²

Medicare, Ozempic, and the GLP-1 Bridge Program

Federal law prohibits Medicare Part D from covering medications prescribed specifically for weight loss.¹³ Aetna Medicare Part D plans follow that rule and cover Ozempic only when it is prescribed for type 2 diabetes.

Starting July 1, 2026, the Medicare GLP-1 Bridge program will give eligible Medicare beneficiaries access to certain weight-loss GLP-1 drugs — specifically Wegovy, Zepbound, and Foundayo — at a fixed $50 monthly copayment. The program runs through December 31, 2027. Ozempic is not included in the Bridge; it covers only drugs with FDA-approved weight-loss indications. Beneficiaries who have type 2 diabetes and already receive GLP-1 coverage through their Part D plan are not eligible.¹⁴

What to Do If Aetna Denies Your Claim

You have the right to appeal any denial, and the clock matters. The main stages:

File an internal appeal within 180 days of the denial notice, by calling Member Services or submitting Aetna’s complaint and appeal form. Include your member ID, the denial letter, and supporting medical records. For plans with one appeal level, Aetna must decide pre-service claims within 30 days. Plans with two levels get 15 days per level.¹⁵
If a delay poses a serious health risk, request an expedited appeal. Aetna must respond within 72 hours for single-level plans or 36 hours for two-level plans.¹⁵
Your prescriber can request a peer-to-peer review with an Aetna medical director to argue the clinical case directly.¹⁶
Once internal appeals are exhausted, the Affordable Care Act gives you the right to a free external review by an independent reviewer. Request it within four months of the final internal denial. The decision is binding on Aetna.¹⁵

For Ozempic specifically, the practical path to a successful appeal is documenting a qualifying diagnosis — type 2 diabetes, established cardiovascular disease, or chronic kidney disease. Appeals built purely on weight-loss grounds run into the plan’s exclusion language and the FDA label.

Ways to Lower the Cost Without Aetna Coverage

Retail prices for Ozempic run roughly $1,000 to $1,200 a month. If your plan will not pay, a few options can bring that down:

The manufacturer savings card. Patients with commercial insurance that covers Ozempic may pay as little as $25 per month, with up to $100 in monthly savings for up to 48 months. The offer does not apply to government insurance beneficiaries.¹⁷
Self-pay pricing through NovoCare. New patients can get the 0.25 mg or 0.5 mg pen for $199 per month for the first two months. Existing patients pay $349 per month for lower doses or $499 per month for the 2 mg pen.¹⁷
The NovoCare Patient Assistance Program provides Ozempic at no cost to eligible U.S. residents who meet income limits and lack prescription drug coverage through Medicare, Medicaid, or other federal programs. The number is 1-866-310-7549.¹⁷
Ask your doctor about Wegovy or Zepbound. If weight loss is the goal, those drugs may open a separate coverage pathway under your plan’s weight-management benefit, if one exists.

1
FDA. Ozempic Prescribing Information
2
UCLA Health. Semaglutide Weight Loss: What You Need to Know
3
Aetna. GLP-1 Agonist Ozempic PA With Limit Policy
4
Aetna. Weight Reduction Programs and Devices
5
National Center for Biotechnology Information. Semaglutide
6
Aetna. 2026 Drug Guide Aetna Standard Plan
7
Aetna. GLP-1 Benefits Coverage
8
Aetna. Customizable Weight Management Solutions
9
Aetna. Wegovy PA With Limit Policy
10
Aetna. Wegovy Cardiovascular PA With Limit Policy
11
Aetna. Zepbound PA With Limit Policy
12
Aetna. Anti-Obesity Agents MI HIDE 2026
13
Aetna. Does Medicare Cover Ozempic
14
CMS. Medicare GLP-1 Bridge Information for Providers
15
Aetna. Claim Denials
16
Aetna. Disputes and Appeals Overview
17
Novo Nordisk. Save on Ozempic